Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XELJANZ (REGISTERED) TABLETS 5MG SPECIAL INVESTIGATION (ALL-CASES SURVEILLANCE)

NCT01932372 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01932372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01932372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XELJANZ (REGISTERED) TABLETS 5MG SPECIAL INVESTIGATION (ALL-CASES SURVEILLANCE)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 26, 2013
Completion date
August 24, 2021
Enrollment
9,968 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis